首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1805992

MMR 疫苗市场报告：趋势、预测和竞争分析（至 2031 年）

MMR Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年09月05日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球MMR疫苗市场前景光明，医院和医疗机构、疫苗接种中心和公共卫生诊所、小儿科和私人诊所都蕴藏着巨大的发展机会。预计2025年至2031年期间，全球MMR疫苗市场的复合年增长率将达到8.3%。推动该市场发展的关键因素包括：大多数国家将MMR疫苗纳入常规儿童免疫接种计划；国际旅行导致的跨境人口流动增加；以及对疫苗安全性和公众教育的重视。

Lucintel 预测，在预测期内，单价疫苗将在类型上实现最高的成长。
从应用来看，医院和医疗机构预计将实现高成长。
按地区划分，预计亚太地区将在预测期内实现最高成长。

MMR疫苗市场的新趋势

全球麻疹、腮腺炎、德国麻疹和德国麻疹疫苗市场正经历重大变革时期，这源于应对不断变化的公共卫生需求、技术进步和社会因素的新趋势。这些趋势正在重塑疫苗的分配方式，提高疫苗的可及性，并应对疫苗犹豫和可负担性等挑战，从而确保在全球范围内实施更有效、更广泛的免疫接种计划。

疫苗接种强制要求和监管力度不断加强：世界各国政府正在强制接种麻腮风（MMR）疫苗，并强制要求入学和出行时接种疫苗。这一趋势显着提高了疫苗接种率，尤其是在已开发国家。更强有力的法律规范和执法政策对于预防疫情爆发和确保群体免疫至关重要。
重视疫苗安全和公众教育：公共卫生官员正在加大力度，透过有针对性的教育宣传活动，打击疫苗错误讯息和犹豫不决。鑑于一些社区对疫苗安全的持续担忧，更加重视透明度、科学传播和社区参与对于维持高接种率至关重要。
全球免疫接种计画扩展：将麻腮风（MMR）疫苗接种计画扩展到中低收入国家（尤其是非洲和亚洲）的势头日益增强。国际组织和各国政府正在携手合作，在服务匮乏的地区扩大疫苗接种，以减轻全球可预防疾病的负担。
联合疫苗和改良剂型：疫苗研发人员正在研发将麻疹、腮腺炎、德国麻疹（MMR）疫苗与其他儿童疫苗（例如水痘）结合的联合疫苗。此类联合疫苗可能对家长更方便，提高免疫依从性，并降低医疗成本。
疫苗注射技术的进步：无针注射系统和微针贴片等新型疫苗注射技术正在麻腮风（MMR）疫苗市场中日益受到关注。这些创新有望提高疫苗的可接受性，减轻注射带来的疼痛和恐惧，并简化偏远地区疫苗宣传活动。

这些新兴趋势正在透过改善疫苗接种方式、扩大疫苗可近性和解决疫苗犹豫问题，改变MMR疫苗的格局。随着各国政府、医疗保健提供者和製造商携手应对疾病预防挑战，这些趋势可望加强全球免疫接种工作，并降低全球麻疹、腮腺炎和德国德国麻疹的发生率。

MMR 疫苗市场的最新趋势

过去几年，全球麻疹、腮腺炎、德国麻疹和腮腺炎 (MMR) 疫苗市场出现了一些显着趋势，这得益于公众意识的提升、疫苗技术的进步以及法律规范的不断演变。这些发展反映了对抗麻疹、流行性腮腺炎和德国德国麻疹等可预防疾病的努力中既面临的挑战，也面临着机会，尤其是在近期疫情和疫苗犹豫情绪日益加剧的情况下。

强制接种疫苗和加强监管：包括德国和美国在内的许多国家都实施了更严格的疫苗接种要求，例如强制入学时接种MMR疫苗。这些监管变化旨在透过确保更多儿童（尤其是在高风险地区）接种疫苗来减少感染疾病爆发并实现更高的疫苗接种覆盖率。
低收入国家进行全球疫苗宣传活动：包括世卫组织和全球疫苗免疫联盟在内的世界卫生组织正在加强力，为医疗资源匮乏的地区提供麻疹、德国麻疹和腮腺炎（MMR）疫苗。这包括在印度和非洲部分地区进行大规模疫苗宣传活动，并专注于疫苗接种覆盖率较低的地区，以降低麻疹和德国麻疹的发生率。
疫苗分发的技术改进：疫苗储存、运输和配送技术的进步正在提高偏远和农村地区麻腮风（MMR）疫苗的可及性。这些技术包括太阳能冰箱和数位追踪系统等创新，对于在资源匮乏的地区维持低温运输，并确保疫苗在运输过程中的完整性至关重要。
合併疫苗以提高覆盖率：MMRV（麻疹、腮腺炎、德国德国麻疹和水痘）等联合疫苗的推广正在加速。这些疫苗可以更有效地安排接种时间，减少所需注射次数，并提高儿童（尤其是幼儿）对疫苗接种计划的依从性。
进行公共卫生宣传活动，解决疫苗犹豫问题：各国政府和公共卫生机构正致力于进行公众教育和宣传，以打击疫苗错误讯息，并提升大众对麻疹、腮腺炎和德国麻疹 (MMR) 疫苗的信心。进行宣传活动，提高公众对疫苗接种安全性和重要性的认识，对于提高接种率和预防疫情爆发至关重要。

麻腮风（MMR）疫苗市场近期的发展凸显了疫苗可及性、技术创新和监管强化的重大进步。随着各国政府和国际组织加强疫苗接种力度，这些进展预计将在提高全球免疫覆盖率和减轻可预防疾病负担方面发挥关键作用。

The future of the global MMR vaccine market looks promising with opportunities in hospitals and healthcare institutions, vaccine centers and public health clinics, and pediatric and private healthcare clinics. The global MMR vaccine market is expected to grow with a CAGR of 8.3% from 2025 to 2031. The major drivers for this market are that the MMR vaccine is included in routine childhood vaccination schedules in most countries, international travel has led to an increase in the movement of populations across borders, and there is a focus on vaccine safety and public education.

Lucintel forecasts that, within the type category, monovalent is expected to witness higher growth over the forecast period.
Within the application category, hospitals and healthcare institutions are expected to witness higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the MMR Vaccine Market

The global MMR vaccine market is undergoing significant transformations as new trends emerge in response to evolving public health needs, technological advancements, and social factors. These trends are reshaping vaccine distribution, improving accessibility, and addressing challenges like vaccine hesitancy and affordability, ensuring more effective and widespread immunization programs globally.

Increase in vaccine mandates and legislation: Governments worldwide are strengthening MMR vaccine mandates, requiring immunization for school enrollment and travel. This trend is significantly boosting vaccination rates, especially in developed nations. Stronger regulatory frameworks and enforcement policies are critical to preventing outbreaks and ensuring herd immunity.
Focus on vaccine safety and public education: Public health authorities are intensifying efforts to combat vaccine misinformation and hesitancy through targeted education campaigns. As concerns over vaccine safety persist in some regions, greater emphasis on transparency, scientific communication, and community engagement is essential to maintaining high vaccination coverage.
Global expansion of immunization programs: There is a growing effort to extend MMR vaccination programs to low- and middle-income countries, especially in Africa and Asia. International organizations and governments are working together to expand access to vaccines in underserved regions, reducing the burden of preventable diseases globally.
Combination vaccines and improved formulations: Vaccine developers are working on combination vaccines that include MMR alongside other childhood vaccines like varicella (chickenpox). These combination vaccines are more convenient for parents, increase vaccination adherence, and reduce healthcare costs, which can be particularly beneficial in regions with limited resources.
Technological advancements in vaccine delivery: New vaccine delivery technologies, such as needle-free injection systems and micro-needle patches, are gaining traction in the MMR vaccine market. These innovations are expected to improve vaccine acceptance, reduce pain or fear of injections, and streamline vaccination campaigns in hard-to-reach areas.

These emerging trends are transforming the MMR vaccine landscape by improving vaccine delivery, expanding access, and addressing vaccine hesitancy. As governments, healthcare providers, and manufacturers collaborate to tackle the challenges of disease prevention, these trends promise to enhance global immunization efforts and reduce the incidence of measles, mumps, and rubella worldwide.

Recent Developments in the MMR Vaccine Market

The global MMR vaccine market has seen several key developments in recent years, driven by increased public awareness, advancements in vaccine technology, and evolving regulatory frameworks. These developments reflect both challenges and opportunities in the effort to combat preventable diseases like measles, mumps, and rubella, particularly in the face of recent outbreaks and growing vaccine hesitancy.

Stronger vaccine mandates and regulations: Many countries, including Germany and the U.S., have implemented stricter vaccination requirements, such as mandatory MMR vaccines for school enrollment. These regulatory changes are aimed at curbing outbreaks and achieving higher vaccination coverage, ensuring that more children are vaccinated, especially in high-risk regions.
Global vaccination campaigns in low-income countries: Global health organizations, including the WHO and GAVI, have ramped up efforts to deliver MMR vaccines to underserved regions. This includes large-scale immunization campaigns in countries like India and parts of Africa, focusing on areas with low vaccine coverage to reduce the incidence of measles and rubella.
Technological improvements in vaccine distribution: Advances in vaccine storage, transportation, and delivery methods are improving MMR vaccine accessibility in remote and rural areas. This includes innovations like solar-powered refrigerators and digital tracking systems, which are essential for maintaining the cold chain in low-resource settings and ensuring the integrity of vaccines during transportation.
Combination vaccines for improved coverage: The introduction of combination vaccines, such as the MMRV (measles, mumps, rubella, and varicella) vaccine, is gaining momentum. These vaccines allow for more efficient vaccination schedules, particularly for young children, reducing the number of injections required and increasing adherence to vaccination programs.
Public health campaigns to address vaccine hesitancy: Governments and public health agencies are focusing on public education and communication to combat vaccine misinformation and improve public confidence in MMR vaccines. Campaigns aimed at increasing awareness about the safety and importance of vaccination are critical to boosting coverage rates and preventing outbreaks.

Recent developments in the MMR vaccine market highlight significant progress in vaccine access, technological innovation, and regulatory enforcement. As governments and global organizations strengthen vaccination efforts, these developments are expected to play a crucial role in increasing global immunization rates and reducing the burden of preventable diseases.

Strategic Growth Opportunities in the MMR Vaccine Market

The global MMR vaccine market is poised for growth, driven by opportunities across key applications such as pediatric vaccination, public health campaigns, and international outreach programs. By focusing on these areas, the market can expand its reach and address vaccine gaps in high-risk populations, especially in developing countries and underserved communities.

Expansion of pediatric immunization programs: As childhood immunization remains a key priority for global health organizations, there is significant growth potential in the pediatric segment. Strengthening national immunization programs and reaching underserved areas will increase vaccine uptake and prevent outbreaks, especially in regions with high birth rates.
Global vaccination campaigns in developing countries: Significant opportunities exist in expanding MMR vaccine access to low-income and middle-income countries, particularly in Africa and Asia. Organizations like GAVI and UNICEF are working to reduce vaccine inequity, providing funding and logistics support to ensure vaccines reach remote and underserved populations.
Focus on vaccine safety and public education initiatives: Educational campaigns aimed at raising awareness about the safety and efficacy of the MMR vaccine represent a growth opportunity, especially in regions where vaccine hesitancy is high. Addressing misinformation through targeted campaigns can help increase vaccination rates and improve public confidence in the vaccine.
Combination vaccines for increased adoption: Combination vaccines that include MMR along with other essential vaccines, such as chickenpox (varicella) and hepatitis B, offer a compelling growth opportunity. These vaccines reduce the number of injections required and improve compliance with vaccination schedules, particularly for young children.
Strengthening healthcare infrastructure in developing regions: Growth opportunities also lie in improving the healthcare infrastructure, particularly in rural and underserved regions. Expanding access to MMR vaccines through mobile clinics, community health workers, and improved cold chain logistics will help improve vaccination coverage and prevent outbreaks in these areas.

Strategic growth opportunities in the MMR vaccine market are primarily driven by expanding access in developing countries, strengthening pediatric vaccination programs, and addressing vaccine hesitancy. As efforts focus on improving accessibility and education, the market has the potential to significantly reduce the burden of measles, mumps, and rubella worldwide.

MMR Vaccine Market Driver and Challenges

The global MMR vaccine market is influenced by a range of drivers and challenges that affect vaccination rates, accessibility, and public health outcomes. These include technological advancements, economic factors, and regulatory policies, as well as challenges like vaccine hesitancy, logistical hurdles, and disparities in healthcare access.

The factors responsible for driving the MMR vaccine market include:

1. Increased government and public health support: Government mandates, such as vaccination requirements for school enrollment, and support from global health organizations like WHO and UNICEF are strong drivers for the MMR vaccine market. These initiatives help expand vaccine coverage, reduce preventable diseases, and ensure higher immunization rates worldwide.

2. Rising awareness of vaccine-preventable diseases: As measles outbreaks increase in certain regions, there is greater awareness of the importance of MMR vaccination. Public health campaigns are educating communities about the risks of vaccine-preventable diseases, driving higher vaccine adoption rates, particularly in developed nations.

3. Improved vaccine accessibility and distribution: Advances in vaccine delivery systems, including better cold chain logistics and digital tracking, are improving access to MMR vaccines, especially in remote and underserved regions. This is helping ensure that vaccines reach populations at risk of preventable diseases.

4. Introduction of combination vaccines: The development and adoption of combination vaccines, such as MMRV (measles, mumps, rubella, and varicella), are helping increase vaccination coverage by reducing the number of injections needed for children. These vaccines simplify immunization schedules, making it easier for parents to comply with vaccination recommendations.

5. International collaboration and funding: Global organizations like GAVI, UNICEF, and the WHO are providing significant funding and logistical support to ensure vaccines reach populations in developing countries. These collaborations are essential for addressing vaccine inequities and improving global immunization rates.

The challenges in the MMR vaccine market are:

1. Vaccine hesitancy and misinformation: Vaccine hesitancy, fueled by misinformation and distrust in vaccines, remains a significant challenge, particularly in high-income countries. Overcoming this challenge requires targeted public education campaigns and transparent communication to build public confidence in the safety and efficacy of the MMR vaccine.

2. Logistical and infrastructure barriers: In many developing regions, inadequate healthcare infrastructure, poor cold chain management, and limited access to healthcare services hinder the effective distribution and delivery of MMR vaccines. These logistical challenges need to be addressed to ensure vaccines reach rural and hard-to-reach areas.

3. Disparities in vaccine access: Disparities in vaccine access, particularly in low- and middle-income countries, continue to impede progress in achieving global immunization goals. Factors such as poverty, conflict, and weak healthcare systems exacerbate these challenges, highlighting the need for targeted intervention and support to reach underserved populations.

The drivers and challenges shaping the global MMR vaccine market reflect a dynamic interplay of factors that influence vaccine adoption, accessibility, and public health outcomes. While increased government support and improved vaccine delivery systems are driving growth, addressing vaccine hesitancy, logistical barriers, and access disparities remains crucial to achieving universal immunization coverage.

List of MMR Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leveraging integration opportunities across the value chain. With these strategies, MMR vaccine companies cater to increasing demand, ensure competitive effectiveness, develop innovative products and technologies, reduce production costs, and expand their customer base. Some of the MMR vaccine companies profiled in this report include:

Merck & Co.
GlaxoSmithKline plc
Pfizer Inc.
Novartis AG
Biological E. Limited

MMR Vaccine Market by Segment

The study includes a forecast for the global MMR vaccine market by type, distribution channel, and region.

MMR Vaccine Market by Type [Value from 2019 to 2031]:

Monovalent
Trivalent
Tetravalent

MMR Vaccine Market by Distribution Channel [Value from 2019 to 2031]:

Hospitals and Healthcare Institutions
Vaccine Centers and Public Health Clinics
Pediatric and Private Healthcare Clinics

MMR Vaccine Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the MMR Vaccine Market

Recent developments in the global MMR vaccine market reflect ongoing efforts to increase vaccination coverage and combat rising cases of preventable diseases. Governments, healthcare providers, and vaccine manufacturers are focusing on expanding access, improving vaccine efficacy, and addressing vaccine hesitancy. In regions like the United States, China, Germany, India, and Japan, key advancements are shaping the future of the MMR vaccine landscape, particularly in light of recent outbreaks.

United States: In the U.S., the MMR vaccine market has seen robust growth due to increased awareness and government mandates, with widespread vaccination programs in schools. Recent efforts focus on addressing vaccine hesitancy, particularly in certain communities, through targeted public health campaigns. Despite high vaccination coverage, localized outbreaks of measles have highlighted the need for continued vigilance and education around the importance of vaccination, ensuring high immunization rates.
China: China has significantly improved its vaccination infrastructure and coverage, with the MMR vaccine being a part of its routine immunization program. The government has been working to strengthen vaccine supply chains and expand access in rural areas. Recent efforts focus on addressing concerns over vaccine safety and increasing public trust. Increased government funding for vaccination programs is also helping expand coverage, reducing the risk of outbreaks.
Germany: Germany has made strides in improving MMR vaccination rates, with a renewed focus on strengthening public health policies. The country recently implemented stricter vaccination requirements, mandating the MMR vaccine for school enrollment to address rising cases of measles. Germany's efforts include educational campaigns to boost public confidence and reduce vaccine hesitancy, particularly in areas with lower vaccination rates. The government's response to recent outbreaks has highlighted the importance of universal vaccination.
India: In India, MMR vaccine coverage has been increasing as part of the national immunization program. The government is focusing on expanding access to vaccines in rural and underserved areas, where healthcare infrastructure is limited. Additionally, India is tackling vaccine hesitancy through community-based programs and educational initiatives. With its large population and high birth rate, India represents a significant market for MMR vaccines, and the government is actively working to reach the remaining unvaccinated groups.
Japan: Japan has maintained high MMR vaccination coverage, but concerns over vaccine safety and side effects have led to public hesitancy in certain regions. The government has responded with educational campaigns to address fears and ensure higher vaccination rates. Japan's national immunization program offers MMR vaccines to children, and recent reforms focus on streamlining vaccine delivery to increase accessibility, particularly in remote areas. Public-private partnerships are also strengthening the distribution network.

Features of the Global MMR Vaccine Market

Market Size Estimates: MMR vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: MMR vaccine market size by type, distribution channel, and region in terms of value ($B).
Regional Analysis: MMR vaccine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, and regions for the MMR vaccine market.
Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the MMR vaccine market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the MMR vaccine market by type (monovalent, trivalent, and tetravalent), distribution channel (hospitals and healthcare institutions, vaccine centers and public health clinics, and pediatric and private healthcare clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global MMR Vaccine Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Monovalent: Trends and Forecast (2019-2031)
4.4 Trivalent: Trends and Forecast (2019-2031)
4.5 Tetravalent: Trends and Forecast (2019-2031)

5. Global MMR Vaccine Market by Distribution Channel

5.1 Overview
5.2 Attractiveness Analysis by Distribution Channel
5.3 Hospitals and Healthcare Institutions: Trends and Forecast (2019-2031)
5.4 Vaccine Centers and Public Health Clinics: Trends and Forecast (2019-2031)
5.5 Pediatric and Private Healthcare Clinics: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global MMR Vaccine Market by Region

7. North American MMR Vaccine Market

7.1 Overview
7.2 North American MMR Vaccine Market by Type
7.3 North American MMR Vaccine Market by Distribution Channel
7.4 United States MMR Vaccine Market
7.5 Mexican MMR Vaccine Market
7.6 Canadian MMR Vaccine Market

8. European MMR Vaccine Market

8.1 Overview
8.2 European MMR Vaccine Market by Type
8.3 European MMR Vaccine Market by Distribution Channel
8.4 German MMR Vaccine Market
8.5 French MMR Vaccine Market
8.6 Spanish MMR Vaccine Market
8.7 Italian MMR Vaccine Market
8.8 United Kingdom MMR Vaccine Market

9. APAC MMR Vaccine Market

9.1 Overview
9.2 APAC MMR Vaccine Market by Type
9.3 APAC MMR Vaccine Market by Distribution Channel
9.4 Japanese MMR Vaccine Market
9.5 Indian MMR Vaccine Market
9.6 Chinese MMR Vaccine Market
9.7 South Korean MMR Vaccine Market
9.8 Indonesian MMR Vaccine Market

10. ROW MMR Vaccine Market

10.1 Overview
10.2 ROW MMR Vaccine Market by Type
10.3 ROW MMR Vaccine Market by Distribution Channel
10.4 Middle Eastern MMR Vaccine Market
10.5 South American MMR Vaccine Market
10.6 African MMR Vaccine Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Distribution Channel
12.3 Emerging Trends in the Global MMR Vaccine Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Merck & Co.
- Company Overview
- MMR Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 GlaxoSmithKline plc
- Company Overview
- MMR Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Pfizer Inc.
- Company Overview
- MMR Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Novartis AG
- Company Overview
- MMR Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Biological E. Limited
- Company Overview
- MMR Vaccine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global MMR Vaccine Market
Figure 2.1: Usage of MMR Vaccine Market
Figure 2.2: Classification of the Global MMR Vaccine Market
Figure 2.3: Supply Chain of the Global MMR Vaccine Market
Figure 2.4: Driver and Challenges of the MMR Vaccine Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 4.1: Global MMR Vaccine Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global MMR Vaccine Market ($B) by Type
Figure 4.3: Forecast for the Global MMR Vaccine Market ($B) by Type
Figure 4.4: Trends and Forecast for Monovalent in the Global MMR Vaccine Market (2019-2031)
Figure 4.5: Trends and Forecast for Trivalent in the Global MMR Vaccine Market (2019-2031)
Figure 4.6: Trends and Forecast for Tetravalent in the Global MMR Vaccine Market (2019-2031)
Figure 5.1: Global MMR Vaccine Market by Distribution Channel in 2019, 2024, and 2031
Figure 5.2: Trends of the Global MMR Vaccine Market ($B) by Distribution Channel
Figure 5.3: Forecast for the Global MMR Vaccine Market ($B) by Distribution Channel
Figure 5.4: Trends and Forecast for Hospitals and Healthcare Institutions in the Global MMR Vaccine Market (2019-2031)
Figure 5.5: Trends and Forecast for Vaccine Centers and Public Health Clinics in the Global MMR Vaccine Market (2019-2031)
Figure 5.6: Trends and Forecast for Pediatric and Private Healthcare Clinics in the Global MMR Vaccine Market (2019-2031)
Figure 6.1: Trends of the Global MMR Vaccine Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global MMR Vaccine Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American MMR Vaccine Market (2019-2031)
Figure 7.2: North American MMR Vaccine Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American MMR Vaccine Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American MMR Vaccine Market ($B) by Type (2025-2031)
Figure 7.5: North American MMR Vaccine Market by Distribution Channel in 2019, 2024, and 2031
Figure 7.6: Trends of the North American MMR Vaccine Market ($B) by Distribution Channel (2019-2024)
Figure 7.7: Forecast for the North American MMR Vaccine Market ($B) by Distribution Channel (2025-2031)
Figure 7.8: Trends and Forecast for the United States MMR Vaccine Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican MMR Vaccine Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian MMR Vaccine Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European MMR Vaccine Market (2019-2031)
Figure 8.2: European MMR Vaccine Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European MMR Vaccine Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European MMR Vaccine Market ($B) by Type (2025-2031)
Figure 8.5: European MMR Vaccine Market by Distribution Channel in 2019, 2024, and 2031
Figure 8.6: Trends of the European MMR Vaccine Market ($B) by Distribution Channel (2019-2024)
Figure 8.7: Forecast for the European MMR Vaccine Market ($B) by Distribution Channel (2025-2031)
Figure 8.8: Trends and Forecast for the German MMR Vaccine Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French MMR Vaccine Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish MMR Vaccine Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian MMR Vaccine Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom MMR Vaccine Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC MMR Vaccine Market (2019-2031)
Figure 9.2: APAC MMR Vaccine Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC MMR Vaccine Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC MMR Vaccine Market ($B) by Type (2025-2031)
Figure 9.5: APAC MMR Vaccine Market by Distribution Channel in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC MMR Vaccine Market ($B) by Distribution Channel (2019-2024)
Figure 9.7: Forecast for the APAC MMR Vaccine Market ($B) by Distribution Channel (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese MMR Vaccine Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian MMR Vaccine Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese MMR Vaccine Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean MMR Vaccine Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian MMR Vaccine Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW MMR Vaccine Market (2019-2031)
Figure 10.2: ROW MMR Vaccine Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW MMR Vaccine Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW MMR Vaccine Market ($B) by Type (2025-2031)
Figure 10.5: ROW MMR Vaccine Market by Distribution Channel in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW MMR Vaccine Market ($B) by Distribution Channel (2019-2024)
Figure 10.7: Forecast for the ROW MMR Vaccine Market ($B) by Distribution Channel (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern MMR Vaccine Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American MMR Vaccine Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African MMR Vaccine Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global MMR Vaccine Market
Figure 11.2: Market Share (%) of Top Players in the Global MMR Vaccine Market (2024)
Figure 12.1: Growth Opportunities for the Global MMR Vaccine Market by Type
Figure 12.2: Growth Opportunities for the Global MMR Vaccine Market by Distribution Channel
Figure 12.3: Growth Opportunities for the Global MMR Vaccine Market by Region
Figure 12.4: Emerging Trends in the Global MMR Vaccine Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the MMR Vaccine Market by Type and Distribution Channel
Table 1.2: Attractiveness Analysis for the MMR Vaccine Market by Region
Table 1.3: Global MMR Vaccine Market Parameters and Attributes
Table 3.1: Trends of the Global MMR Vaccine Market (2019-2024)
Table 3.2: Forecast for the Global MMR Vaccine Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global MMR Vaccine Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global MMR Vaccine Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global MMR Vaccine Market (2025-2031)
Table 4.4: Trends of Monovalent in the Global MMR Vaccine Market (2019-2024)
Table 4.5: Forecast for Monovalent in the Global MMR Vaccine Market (2025-2031)
Table 4.6: Trends of Trivalent in the Global MMR Vaccine Market (2019-2024)
Table 4.7: Forecast for Trivalent in the Global MMR Vaccine Market (2025-2031)
Table 4.8: Trends of Tetravalent in the Global MMR Vaccine Market (2019-2024)
Table 4.9: Forecast for Tetravalent in the Global MMR Vaccine Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global MMR Vaccine Market by Distribution Channel
Table 5.2: Market Size and CAGR of Various Distribution Channel in the Global MMR Vaccine Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Distribution Channel in the Global MMR Vaccine Market (2025-2031)
Table 5.4: Trends of Hospitals and Healthcare Institutions in the Global MMR Vaccine Market (2019-2024)
Table 5.5: Forecast for Hospitals and Healthcare Institutions in the Global MMR Vaccine Market (2025-2031)
Table 5.6: Trends of Vaccine Centers and Public Health Clinics in the Global MMR Vaccine Market (2019-2024)
Table 5.7: Forecast for Vaccine Centers and Public Health Clinics in the Global MMR Vaccine Market (2025-2031)
Table 5.8: Trends of Pediatric and Private Healthcare Clinics in the Global MMR Vaccine Market (2019-2024)
Table 5.9: Forecast for Pediatric and Private Healthcare Clinics in the Global MMR Vaccine Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global MMR Vaccine Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global MMR Vaccine Market (2025-2031)
Table 7.1: Trends of the North American MMR Vaccine Market (2019-2024)
Table 7.2: Forecast for the North American MMR Vaccine Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American MMR Vaccine Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American MMR Vaccine Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Distribution Channel in the North American MMR Vaccine Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Distribution Channel in the North American MMR Vaccine Market (2025-2031)
Table 7.7: Trends and Forecast for the United States MMR Vaccine Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican MMR Vaccine Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian MMR Vaccine Market (2019-2031)
Table 8.1: Trends of the European MMR Vaccine Market (2019-2024)
Table 8.2: Forecast for the European MMR Vaccine Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European MMR Vaccine Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European MMR Vaccine Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Distribution Channel in the European MMR Vaccine Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Distribution Channel in the European MMR Vaccine Market (2025-2031)
Table 8.7: Trends and Forecast for the German MMR Vaccine Market (2019-2031)
Table 8.8: Trends and Forecast for the French MMR Vaccine Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish MMR Vaccine Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian MMR Vaccine Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom MMR Vaccine Market (2019-2031)
Table 9.1: Trends of the APAC MMR Vaccine Market (2019-2024)
Table 9.2: Forecast for the APAC MMR Vaccine Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC MMR Vaccine Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC MMR Vaccine Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Distribution Channel in the APAC MMR Vaccine Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Distribution Channel in the APAC MMR Vaccine Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese MMR Vaccine Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian MMR Vaccine Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese MMR Vaccine Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean MMR Vaccine Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian MMR Vaccine Market (2019-2031)
Table 10.1: Trends of the ROW MMR Vaccine Market (2019-2024)
Table 10.2: Forecast for the ROW MMR Vaccine Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW MMR Vaccine Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW MMR Vaccine Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Distribution Channel in the ROW MMR Vaccine Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Distribution Channel in the ROW MMR Vaccine Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern MMR Vaccine Market (2019-2031)
Table 10.8: Trends and Forecast for the South American MMR Vaccine Market (2019-2031)
Table 10.9: Trends and Forecast for the African MMR Vaccine Market (2019-2031)
Table 11.1: Product Mapping of MMR Vaccine Suppliers Based on Segments
Table 11.2: Operational Integration of MMR Vaccine Manufacturers
Table 11.3: Rankings of Suppliers Based on MMR Vaccine Revenue
Table 12.1: New Product Launches by Major MMR Vaccine Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global MMR Vaccine Market

02-2729-4219

+886-2-2729-4219

License/价格

MMR 疫苗市场报告：趋势、预测和竞争分析（至 2031 年）

MMR Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

目录

第一章执行摘要

第二章市场概述

第三章：市场趋势与预测分析

4. 全球 MMR 疫苗市场（按类型）

5. 全球 MMR 疫苗市场（依分销管道）

第六章区域分析

7.北美MMR疫苗市场

8. 欧洲MMR疫苗市场

9. 亚太地区 MMR 疫苗市场

10. 世界其他地区 (ROW) MMR 疫苗市场

第十一章竞争分析

第十二章机会与策略分析

第十三章价值链主要企业概况

第十四章附录

MMR Vaccine Market by Type [Value from 2019 to 2031]:

MMR Vaccine Market by Distribution Channel [Value from 2019 to 2031]:

MMR Vaccine Market by Region [Value from 2019 to 2031]:

This report answers the following 11 key questions: